PET/MRI in the Diagnosis of Chronic Pain

Description

Several studies have implicated involvement of sigma-1 receptors (SR1s) in the generation of chronic pain, while others are investigating anti SR1 drugs for treatment of chronic pain. Using \[18F\]-FTC-146 and positron emission tomography/magnetic resonance imaging (PET/MRI), the investigators hope to identify the source of pain generation in patients with chronic pain. The purpose of this study is to compare the uptake of \[18F\]FTC-146 in healthy volunteers to that of individuals suffering from chronic pain.

Conditions

Neuropathic Pain, Nociceptive Pain, Mixed Pain (Nociceptive and Neuropathic), Spinal Pain, Radiculopathy, Myelopathy, Neurogenic Claudication

Study Overview

Study Details

Study overview

Several studies have implicated involvement of sigma-1 receptors (SR1s) in the generation of chronic pain, while others are investigating anti SR1 drugs for treatment of chronic pain. Using \[18F\]-FTC-146 and positron emission tomography/magnetic resonance imaging (PET/MRI), the investigators hope to identify the source of pain generation in patients with chronic pain. The purpose of this study is to compare the uptake of \[18F\]FTC-146 in healthy volunteers to that of individuals suffering from chronic pain.

Use of [18F]FTC-146 PET/MRI in the Diagnosis of Chronic Pain

PET/MRI in the Diagnosis of Chronic Pain

Condition
Neuropathic Pain
Intervention / Treatment

-

Contacts and Locations

Stanford

Stanford University, Stanford, California, United States, 94305

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. At least 18 years old.
  • 2. Covid Vaccination status: Vaccinated or unvaccinated subjects who received a negative test result from the Covid test within 72 hours of the scan.
  • 1. At least 18 years old.
  • 2. Chronic pain (nociceptive, neuropathic or mixed pain) lasting greater than 2 months.
  • 3. Pain level of at least 4/10 on a 0-10 Comparative Pain Scale.
  • 4. Covid Vaccination status: Vaccinated or unvaccinated subjects who received a negative test result from the Covid test within 72 hours of the scan.
  • 1. Pain
  • 2. Pain Medication
  • 3. MRI incompatible
  • 4. Pregnant or nursing
  • 5. Non-English speaker
  • 6. Claustrophobic
  • 1. MRI incompatible
  • 2. Pregnant or nursing
  • 3. Non-English speaker
  • 4. Claustrophobic

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Stanford University,

Anand Veeravagu, MD, PRINCIPAL_INVESTIGATOR, Stanford University Department of Neurosurgery

Study Record Dates

2024-12-31